Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

NCT06121505 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Lung Squamous Cell Carcinoma

Interventions

RADIATION: low-dose radiation therapy and stereotactic body radiation therapy
DRUG: chemotherapy
DRUG: Sintilimab

Sponsor

Sichuan University

Collaborators

[object Object]